Evaluation of Pancreatobiliary Disorders in Patients With Altered Gastric Anatomy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01238341 |
|
Recruitment Status :
Completed
First Posted : November 10, 2010
Results First Posted : October 5, 2015
Last Update Posted : October 23, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Pancreatobiliary Disease Altered Gastric Anatomy | Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP) |
| Study Type : | Observational |
| Actual Enrollment : | 7 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Official Title: | Prospective Evaluation of Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) With Overtube in Patients With Altered Gastric Anatomy |
| Study Start Date : | June 2007 |
| Actual Primary Completion Date : | July 2015 |
| Actual Study Completion Date : | July 2015 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Pancreatobiliary disease
Patients who have altered gastric anatomy who need an ERCP with an overtube for evaluation of pancreatobiliary disease.
|
Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP)
An Endoscopic Retrograde Cholangiopancreatography (ERCP) performed with an overtube in the evaluation of pancreatobiliary disease in patients with altered gastric anatomy |
- Papilla or Duct-enterostomy Was Reached [ Time Frame: During procedure, up to 3 hours ]
- Successful Cannulation of the Duct of Intent [ Time Frame: During procedure, up to 3 hours ]Deep cannulation of the bile/pancreatic duct was indicated in 12 of 13 ERCPs, one procedure was performed for stent removal only. This outcome was only relevant when deep cannulation was clinically indicated, therefore this outcome was determined out of 12 ERCPs.
- Successful Endoscopic Therapy [ Time Frame: During procedure, up to 3 hours ]
- Total Procedure Time [ Time Frame: During procedure, up to 3 hours ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subject is 18 years or older
- Subject has medical indication for Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Subject has altered gastric anatomy
- Subject must be able to give informed consent.
Exclusion Criteria:
- Any contraindication for Endoscopic Retrograde Cholangiopancreatography (ERCP) with overtube
- The subject is unable to give informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01238341
| United States, Florida | |
| Shands at UF Endoscoppy Center | |
| Gainesville, Florida, United States, 32608 | |
| Principal Investigator: | Peter Draganov, MD | University of Florida |
| Responsible Party: | University of Florida |
| ClinicalTrials.gov Identifier: | NCT01238341 |
| Other Study ID Numbers: |
Pancreatobiliary disorders |
| First Posted: | November 10, 2010 Key Record Dates |
| Results First Posted: | October 5, 2015 |
| Last Update Posted: | October 23, 2015 |
| Last Verified: | October 2015 |
|
Pancreatobiliary disease in patients with altered gastric anatomy. |

